-
An experimental new class of drugs is aimed at rendering TGF-beta and CTGF ineffective by blocking their ability to bind with cell receptors.
FORBES: Scar Wars
-
In the wake of his results Roche have begun testing an old class of experimental anxiety drugs called mGluR5 inhibitors in fragile X patients.
FORBES: The Man Behind Biotech's Bold Push For Autism Drugs
-
In the wake of his results Roche and Novartis have begun testing an old class of experimental anxiety drugs called mGluR5 inhibitors in fragile X patients.
FORBES: Magazine Article
-
It also highlights the promise of a class of experimental medicines, designed as successors to Actos and other drugs like it, that aim to correct cholesterol and triglyceride levels as well.
FORBES: Magazine Article